(Q47968165)

7 February 2018

title

Th1-mediated experimental autoimmune encephalomyelitis is CXCR3 independent (English)

1 reference

7 February 2018

experimental autoimmune encephalomyelitis

main subject

1 reference

2

1 reference

7 February 2018

Stephen J. Lalor

object named as

Stephen J Lalor

series ordinal

1

0 references

language of work or name

English

0 references

publication date

21 August 2013

1 reference

7 February 2018

European Journal of Immunology

published in

1 reference

7 February 2018

volume

43

1 reference

7 February 2018

issue

11

1 reference

7 February 2018

page(s)

2866-2874

1 reference

7 February 2018

https://api.crossref.org/works/10.1002%2FEJI.201343499

1 reference

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Foxp3⁺ Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

T-bet is required for optimal proinflammatory CD4+ T-cell trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

IFN-beta inhibits human Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Fate mapping of IL-17-producing T cells in inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Opportunistic infections and other risks with newer multiple sclerosis therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Requirement of the chemokine receptor CXCR3 for acute allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

7 January 2021

Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

7 January 2021

Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

7 January 2021

Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

7 January 2021

Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

7 January 2021

Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343499

7 January 2021

Identifiers

DOI

10.1002/EJI.201343499

1 reference

7 February 2018

1 reference

7 February 2018